CN101757540A - Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof Download PDFInfo
- Publication number
- CN101757540A CN101757540A CN200910309194A CN200910309194A CN101757540A CN 101757540 A CN101757540 A CN 101757540A CN 200910309194 A CN200910309194 A CN 200910309194A CN 200910309194 A CN200910309194 A CN 200910309194A CN 101757540 A CN101757540 A CN 101757540A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 206010029164 Nephrotic syndrome Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 35
- 238000011282 treatment Methods 0.000 claims abstract description 23
- 241000005787 Cistanche Species 0.000 claims abstract description 10
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 241000756943 Codonopsis Species 0.000 claims description 9
- 241000190633 Cordyceps Species 0.000 claims description 9
- 241000600871 Euryale <brittle star> Species 0.000 claims description 9
- 241000222336 Ganoderma Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 210000003038 endothelium Anatomy 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 9
- 239000008517 radix Trichosanthis Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 4
- 239000010271 massa medicata fermentata Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 12
- 208000003623 Hypoalbuminemia Diseases 0.000 abstract description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 4
- 206010022437 insomnia Diseases 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000241872 Lycium chinense Species 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- 240000005373 Panax quinquefolius Species 0.000 abstract 2
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000209020 Cornus Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 244000268590 Euryale ferox Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 206010024642 Listless Diseases 0.000 abstract 1
- 240000001307 Myosotis scorpioides Species 0.000 abstract 1
- 244000270834 Myristica fragrans Species 0.000 abstract 1
- 235000009421 Myristica fragrans Nutrition 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 235000008434 ginseng Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 208000017971 listlessness Diseases 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 201000001474 proteinuria Diseases 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 description 24
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 210000002700 urine Anatomy 0.000 description 14
- 239000002994 raw material Substances 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 7
- 239000005556 hormone Substances 0.000 description 7
- 238000002636 symptomatic treatment Methods 0.000 description 6
- 206010001580 Albuminuria Diseases 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010018092 Generalised oedema Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 208000024783 anasarca Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010027175 memory impairment Diseases 0.000 description 3
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
- 229960004618 prednisone Drugs 0.000 description 3
- 150000003118 prednisones Chemical class 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000002562 urinalysis Methods 0.000 description 2
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010011655 Cushingoid Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020651 Hyperkinesia Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 206010062315 Lipohypertrophy Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 231100000852 glomerular disease Toxicity 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 229940095529 heparin calcium Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003055 low molecular weight heparin Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a new traditional Chinese medicine composition for treating nephrotic syndrome and a preparation method thereof. The traditional Chinese medicine composition mainly comprises the following Chinese medicinal herbs such as American ginseng, ginseng, codonopsis pilosula, unprocessed astragalus mongholicus, Chinese yam, turtle shell, tortoise plastron, cornu cervi degelatinatum, fruit of Chinese wolfberry, root of Chinese trichosanthes, fruit of Chinese magnoliavine, seed of Chinese dodder, herba cistanche, Chinese caterpillar fungus, prepared rehmannia root, polygonum multiflorum, fructus ligustri lucidi, dried orange peel, myristica fragrans, fructus amomi, semen euryales, mangnolia officinalis, fructus chebulae, fructus rosae laevigatae, fructus alpiniae oxyphyllae, oyster, drynaria rhizome, dogwood, root-bark of Chinese wolfberry, phellodendron, fructus gardenia, white atractylodes rhizome, lucid asparagus, ophiopogon japonicus, herba epimedii, rhizoma anemarrhenae, root of kudzu vine and the like. The traditional Chinese medicine composition can be prepared into any one common oral preparation according to a conventional traditional Chinese medicine preparation method. The invention can remarkably improve symptoms of proteinuria, hypoalbuminemia, hematuresis, generaldropsy, listlessness, poor physical strength, inappetence, insomnia and amnesia, hypomnesis and the like of the patients suffering from the nephrotic syndrome and has accurate clinical treatment effect, remarkable treatment effect and rapid effect taking. Because of being combined by basically adopting medicinal and edible medicines specified in National Formulary, the invention has the advantages of low cost, basically no toxic and side effects and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of nephrotic syndrome.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment nephrotic syndrome of crude drug with the Chinese herbal medicine.
Background technology
Nephrotic syndrome is not a kind of independence disease, but one group of clinical syndrome in the renal glomerular disease.Disease causes that damage, infection, medicine, tumor and the diabetes etc. of glomerular capillary filter membrane all can cause the generation of nephrotic syndrome.Clinical manifestation is symptoms such as a large amount of albuminuria, hypoalbuminemia, edema companion, treat timely and effectively as not taking, normal easily the initiation sends out sore infection, hypercoagulability and venous thrombosis, acute renal failure, renal tubular function go down, bone and the multiple diseases that have a strong impact on Health and Living such as abnormal calcium metabolism, endocrine and Developmental and Metabolic Disorder, and the clinical onset rate has the trend of continuous rising in recent years.
There is not the specific treatment method at present, the symptom that is primarily aimed at clinical manifestation adopts symptomatic treatments such as hormone, immunosuppressant, anticoagulant, often fall flat, and side effect is big, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment nephrotic syndrome, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical the accent, emergency is taken in concurrently, filters out the natural plant of eliminating toxic substances to remove stasis, inducing diuresis to remove edema, nourishing the liver and kidney, according to the theory of Chinese medical science prescription, be prepared from according to certain weight proportion.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment nephrotic syndrome that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment nephrotic syndrome of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of nephrotic syndrome of the present invention, the component of main following weight portion is formed:
Radix Panacis Quinquefolii 1～20 gram, the person 1～30 gram, Radix Codonopsis 1～50 gram, Radix Astragali 1～50 gram, Ganoderma 1～30 gram, Radix Angelicae Sinensis 1～50 gram, the Radix Paeoniae Alba 1～50 gram, RHIIZOMA DIOSCOREAE frOm Henan of China 1～50 gram, Carapax Trionycis 1～30 gram, Carapax et Plastrum Testudinis～30 grams, Cornu Cervi Degelatinatum 1～30 gram, Radix Rehmanniae 1～40 gram, Fructus Lycii 1～40 gram, Radix Trichosanthis 1～40 gram, Fructus Schisandrae Chinensis 1～40 gram, Semen Cuscutae 1～30 gram, Herba Cistanches 1～40 gram, Cordyceps 1～30 gram, Radix Rehmanniae Preparata 1～40 gram, Radix Polygoni Multiflori 1～40 gram, Massa Medicata Fermentata 1～50 gram, Fructus Hordei Germinatus 1～40 gram, Semen Arecae 1～40 gram, Fructus Ligustri Lucidi 1～30 gram, Pericarpium Citri Reticulatae 1～50 gram, Rhizoma Cyperi 1～40 gram, Semen Myristicae 1～30 gram, Fructus Amomi 1～30 gram, Endothelium Corneum Gigeriae Galli 1～30 gram, Semen Euryales 1～40 gram.
Be preferably:
Radix Panacis Quinquefolii 6 grams, the person 10 grams, Radix Codonopsis 20 grams, Radix Astragali 30 grams, Ganoderma 10 grams, Radix Angelicae Sinensis 30 grams, the Radix Paeoniae Alba 30 grams, RHIIZOMA DIOSCOREAE frOm Henan of China 30 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Cornu Cervi Degelatinatum 10 grams, Radix Rehmanniae 15 grams, Fructus Lycii 20 grams, Radix Trichosanthis 20 grams, Fructus Schisandrae Chinensis 20 grams, Semen Cuscutae 15 grams, Herba Cistanches 10 grams, Cordyceps 10 grams, Radix Rehmanniae Preparata 15 grams, Radix Polygoni Multiflori 20 grams, Massa Medicata Fermentata 30 grams, Fructus Hordei Germinatus 20 grams, Semen Arecae 15 grams, Fructus Ligustri Lucidi 15 grams, Pericarpium Citri Reticulatae 30 grams, Rhizoma Cyperi 30 grams, Semen Myristicae 20 grams, Fructus Amomi 15 grams, Endothelium Corneum Gigeriae Galli 15 grams, Semen Euryales 20 grams.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
Semen Ziziphi Spinosae 1～30 gram, Semen Raphani 1～30 gram, Fructus Crataegi 1～30 gram, Cortex Magnoliae Officinalis 1～30 gram, Fructus Chebulae's 1～30 gram, Fructus Mume 1～40 gram, Fructus Rosae Laevigatae 1～30 gram, Fructus Alpiniae Oxyphyllae 1～30 gram, Ootheca Mantidis 1～30 gram, Endoconcha Sepiae 1～30 gram, Concha Ostreae 1～30 gram, Rhizoma Drynariae 1～30 gram, Fructus Corni 1～40 gram, Cortex Lycii 1～50 gram, Cortex Phellodendri 1～40 gram, Fructus Gardeniae 1～30 gram, Radix Adenophorae (Radix Glehniae) 1～40 gram, Herba Dendrobii 1～40 gram, Rhizoma Polygonati Odorati 1～40 gram, the Rhizoma Atractylodis Macrocephalae 1～40 gram, Radix Asparagi 1～40 gram, Radix Ophiopogonis 1～40 gram, Herba Epimedii 1～30 gram, Radix Morindae Officinalis 1～30 gram, the Rhizoma Anemarrhenae 1～30 gram, Radix Puerariae 1～50 gram.
Be preferably:
Semen Ziziphi Spinosae 12 gram, Semen Raphani 20 grams, Fructus Crataegi 15 grams, Cortex Magnoliae Officinalis 20 grams, Fructus Chebulae's 15 grams, Fructus Mume 20 grams, Fructus Rosae Laevigatae 15 grams, Fructus Alpiniae Oxyphyllae 20 grams, Ootheca Mantidis 15 grams, Endoconcha Sepiae 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 15 grams, Fructus Corni 15 grams, Cortex Lycii 30 grams, Cortex Phellodendri 20 grams, Fructus Gardeniae 20 grams, Radix Adenophorae (Radix Glehniae) 15 grams, Herba Dendrobii 15 grams, Rhizoma Polygonati Odorati 15 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Radix Asparagi 20 grams, Radix Ophiopogonis 20 grams, Herba Epimedii 15 grams, Radix Morindae Officinalis 15 grams, the Rhizoma Anemarrhenae 15 grams, Radix Puerariae 30 gram.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.This is the important content of Thailand one and Pu (Beijing) Chinese medicine academy patent strategy.
The structure of Thailand one and Pu patent strategy is convenient to Chinese medicine and is realized standardization, scale, industrialization, modernization and industrialization.For traditional Chinese medicine development has been opened up a road that meets the Chinese medicine self-law with innovation.The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to the nephrotic syndrome patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: Radix Panacis Quinquefolii 6 grams, the person 10 grams, Radix Codonopsis 20 grams, Radix Astragali 30 grams, Ganoderma 10 grams, Radix Angelicae Sinensis 30 grams, the Radix Paeoniae Alba 30 grams, RHIIZOMA DIOSCOREAE frOm Henan of China 30 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Cornu Cervi Degelatinatum 10 grams, Radix Rehmanniae 15 grams, Fructus Lycii 20 grams, Radix Trichosanthis 20 grams, Fructus Schisandrae Chinensis 20 grams, Semen Cuscutae 15 grams, Herba Cistanches 10 grams, Cordyceps 10 grams, Fructus Ligustri Lucidi 15 grams, Pericarpium Citri Reticulatae 30 grams, Endothelium Corneum Gigeriae Galli 15 grams, Semen Euryales 20 grams, Fructus Chebulae's 15 grams, Fructus Mume 20 grams, Fructus Rosae Laevigatae 15 grams, Fructus Alpiniae Oxyphyllae 20 grams, Ootheca Mantidis 15 grams, Endoconcha Sepiae 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 15 grams, Fructus Corni 15 grams, Cortex Lycii 30 grams, Cortex Phellodendri 20 grams, Fructus Gardeniae 20 grams, Radix Asparagi 20 grams, Radix Ophiopogonis 20 grams, Herba Epimedii 15 grams, Radix Morindae Officinalis 15 grams, the Rhizoma Anemarrhenae 15 grams, Radix Puerariae 30 grams.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: Radix Panacis Quinquefolii 6 grams, the person 10 grams, Radix Codonopsis 20 grams, Radix Astragali 30 grams, Ganoderma 10 grams, Radix Angelicae Sinensis 30 grams, the Radix Paeoniae Alba 30 grams, RHIIZOMA DIOSCOREAE frOm Henan of China 30 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Cornu Cervi Degelatinatum 10 grams, Radix Rehmanniae 15 grams, Fructus Lycii 20 grams, Radix Trichosanthis 20 grams, Fructus Schisandrae Chinensis 20 grams, Semen Cuscutae 15 grams, Herba Cistanches 10 grams, Cordyceps 10 grams, Fructus Ligustri Lucidi 15 grams, Pericarpium Citri Reticulatae 30 grams, Endothelium Corneum Gigeriae Galli 15 grams, Semen Euryales 20 grams, Fructus Chebulae's 15 grams, Fructus Mume 20 grams, Fructus Rosae Laevigatae 15 grams, Fructus Alpiniae Oxyphyllae 20 grams, Ootheca Mantidis 15 grams, Endoconcha Sepiae 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 15 grams, Fructus Corni 15 grams, Cortex Lycii 30 grams, Cortex Phellodendri 20 grams, Fructus Gardeniae 20 grams, Radix Asparagi 20 grams, Radix Ophiopogonis 20 grams, Herba Epimedii 15 grams, Radix Morindae Officinalis 15 grams, the Rhizoma Anemarrhenae 15 grams, Radix Puerariae 30 grams.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material according to following weight portion: Radix Panacis Quinquefolii 6 grams, the person 10 grams, Radix Codonopsis 20 grams, Radix Astragali 30 grams, Ganoderma 10 grams, Radix Angelicae Sinensis 30 grams, the Radix Paeoniae Alba 30 grams, RHIIZOMA DIOSCOREAE frOm Henan of China 30 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Cornu Cervi Degelatinatum 10 grams, Radix Rehmanniae 15 grams, Fructus Lycii 20 grams, Radix Trichosanthis 20 grams, Fructus Schisandrae Chinensis 20 grams, Semen Cuscutae 15 grams, Herba Cistanches 10 grams, Cordyceps 10 grams, Fructus Ligustri Lucidi 15 grams, Pericarpium Citri Reticulatae 30 grams, Endothelium Corneum Gigeriae Galli 15 grams, Semen Euryales 20 grams, Fructus Chebulae's 15 grams, Fructus Mume 20 grams, Fructus Rosae Laevigatae 15 grams, Fructus Alpiniae Oxyphyllae 20 grams, Ootheca Mantidis 15 grams, Endoconcha Sepiae 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 15 grams, Fructus Corni 15 grams, Cortex Lycii 30 grams, Cortex Phellodendri 20 grams, Fructus Gardeniae 20 grams, Radix Asparagi 20 grams, Radix Ophiopogonis 20 grams, Herba Epimedii 15 grams, Radix Morindae Officinalis 15 grams, the Rhizoma Anemarrhenae 15 grams, Radix Puerariae 30 grams.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material according to following weight portion: Radix Panacis Quinquefolii 6 grams, the person 10 grams, Radix Codonopsis 20 grams, Radix Astragali 30 grams, Ganoderma 10 grams, Radix Angelicae Sinensis 30 grams, the Radix Paeoniae Alba 30 grams, RHIIZOMA DIOSCOREAE frOm Henan of China 30 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Cornu Cervi Degelatinatum 10 grams, Radix Rehmanniae 15 grams, Fructus Lycii 20 grams, Radix Trichosanthis 20 grams, Fructus Schisandrae Chinensis 20 grams, Semen Cuscutae 15 grams, Herba Cistanches 10 grams, Cordyceps 10 grams, Fructus Ligustri Lucidi 15 grams, Pericarpium Citri Reticulatae 30 grams, Endothelium Corneum Gigeriae Galli 15 grams, Semen Euryales 20 grams, Fructus Chebulae's 15 grams, Fructus Mume 20 grams, Fructus Rosae Laevigatae 15 grams, Fructus Alpiniae Oxyphyllae 20 grams, Ootheca Mantidis 15 grams, Endoconcha Sepiae 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 15 grams, Fructus Corni 15 grams, Cortex Lycii 30 grams, Cortex Phellodendri 20 grams, Fructus Gardeniae 20 grams, Radix Asparagi 20 grams, Radix Ophiopogonis 20 grams, Herba Epimedii 15 grams, Radix Morindae Officinalis 15 grams, the Rhizoma Anemarrhenae 15 grams, Radix Puerariae 30 grams.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material according to following weight portion: Radix Panacis Quinquefolii 6 grams, the person 10 grams, Radix Codonopsis 20 grams, Radix Astragali 30 grams, Ganoderma 10 grams, Radix Angelicae Sinensis 30 grams, the Radix Paeoniae Alba 30 grams, RHIIZOMA DIOSCOREAE frOm Henan of China 30 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Cornu Cervi Degelatinatum 10 grams, Radix Rehmanniae 15 grams, Fructus Lycii 20 grams, Radix Trichosanthis 20 grams, Fructus Schisandrae Chinensis 20 grams, Semen Cuscutae 15 grams, Herba Cistanches 10 grams, Cordyceps 10 grams, Fructus Ligustri Lucidi 15 grams, Pericarpium Citri Reticulatae 30 grams, Endothelium Corneum Gigeriae Galli 15 grams, Semen Euryales 20 grams, Fructus Chebulae's 15 grams, Fructus Mume 20 grams, Fructus Rosae Laevigatae 15 grams, Fructus Alpiniae Oxyphyllae 20 grams, Ootheca Mantidis 15 grams, Endoconcha Sepiae 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 15 grams, Fructus Corni 15 grams, Cortex Lycii 30 grams, Cortex Phellodendri 20 grams, Fructus Gardeniae 20 grams, Radix Asparagi 20 grams, Radix Ophiopogonis 20 grams, Herba Epimedii 15 grams, Radix Morindae Officinalis 15 grams, the Rhizoma Anemarrhenae 15 grams, Radix Puerariae 30 grams.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into rule
Fixed concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating nephrotic syndrome of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 139 routine patients altogether, wherein male 83 examples, women 56 examples; The oldest person 77 years old, the age reckling has only 5 years old.
Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 9 courses of treatment altogether.
The therapeutic evaluation standard
Cure: on inspection: albuminuria, hypoalbuminemia, hematuria are normal fully, and edema disappears, and is in high spirits, antisecosis, and the normal or significantly increase of appetite, symptoms such as insomnia forgetfulness, hypomnesis are normal substantially.
Produce effects: on inspection: albuminuria, hypoalbuminemia, hematuria are near normal, and edema disappears, and is in high spirits, antisecosis, and appetite increases, and symptoms such as insomnia forgetfulness, hypomnesis are significantly recovered.
Effectively: on inspection: albuminuria, hypoalbuminemia, hematuria are obviously improved, and edema disappears substantially, and spirit takes a turn for the better, and health is stronger, and appetite increases, doing well,improvings such as insomnia forgetfulness, hypomnesis.
Invalid: index no change or change not obviously, sign does not have change substantially, symptom basic as before.
Model case:
1, Wu, man, 27 years old, workman.
It is surplus to suffer from nephrotic syndrome 4 years, through the treatment stable disease.Flu back recurrence before half a year, urine protein (++ ++) at that time, the height edema is in hospital with Drug therapys such as prednisones, and the state of an illness takes a turn for the better gradually, and urine protein is turned out cloudy, and edema fades.But knock-on appears in 15 milligram hours next day that prednisone reduces to, urine protein (++ ++), ask tcm diagnosis and treatment then.It is red and impractical to examine meeting, and the whole body is weak, the soreness of waist, yellowish urine.Tongue is dark red, and tongue is greasy in vain, stringy and rolling pulse.Routine urinalysis: albumen (+++), 5～7 of leukocyte.Took Chinese medicine composition of the present invention 1 month, during flu 1 time, stable disease is withdrawn prednisone, it is surplus March to take Chinese medicine composition of the present invention again, above-mentioned symptom disappears, urine examination feminine gender, stable disease.
2, congratulate certain, man, 18 years old, student.
Began to suffer from nephrotic syndrome in 2 years old.Each flu then disease recurs and increases the weight of, and very then the whole body serious edema must increase the weight of hormone dosage, takes the Chinese medicine of relieving the exterior syndrome by diaphoresis simultaneously orally, and the state of an illness could be alleviated.When the state of an illness is steady, then take LIUWEI DIHUANG WAN and JINGUI SHENQI WAN Zhi Qiben.Can be still poor because of child's resistance, only obey coldrex, be difficult to adhere to, so that the state of an illness is touching does not heal, not the clothes coldrexs for many years, promptly be the clothes prednisones.Take Chinese medicine composition of the present invention after 1 month, symptom is significantly improved, and it is surplus May to take Chinese medicine composition of the present invention again, and above-mentioned symptom disappears, during catch a cold 3 times, stable disease is followed up a case by regular visits to and is not had recurrence so far.
3, fur coat, man, 7 years old.
Intend examining nephrotic syndrome companion chronic renal insufficiency through certain hospital, the February of being in hospital is surplus, repeatedly through various western medicines, fail to produce effects, school has fallen ill to endanger and has notified patient's pale complexion when examining, the manner rope that disappears, anasarca, enlarged abdomen such as drum, breast is born high prominent, and the scrotum enlargement is bright, under the stool drop difficulty, faint and thready pulse wild, corpulent tongue, pale tongue, greasy fur neatly.Take Chinese medicine composition of the present invention after 15 days, hydrouria, edema subtracts greatly, and scrotum is swollen to move back to the greatest extent substantially, and expression is active, and thready pulse has god, and it is surplus March to take Chinese medicine composition of the present invention again, and all diseases disappear entirely, and health check-up is chemically examined all in normal range, follows up a case by regular visits to not recurrence in 2 years.
4, poplar, woman, 21 years old, student.
No obvious inducement before 2 years, and eyelid and edema of pair of lower extremities occur, and albuminuria http://www.sjzsbyy.com/danbain fourth, low molecular heparin calcium occur " etc. behind the symptomatic treatment, remission.But before one month, do not have obvious inducement, and eyes eyelid moderate edema appears once more, two lower limb refer to the concavity edema, lassitude, diet, the sleep inequality.Take Chinese medicine composition of the present invention after 20 days, symptom is significantly improved, and it is surplus March to take Chinese medicine composition of the present invention again, and above-mentioned symptom all disappears, stable disease.
5, the week certain, man, 5 years old.
Anasarca appears in patient's no obvious inducement before 1 year, does albumen 2+ have urine examined? +, be diagnosed as " acute nephritis ", mainly use the hormone symptomatic treatment, edema disappears after 10 days, and urine protein is turned out cloudy.But after going home three days, because anasarca appears again in hyperkinesia.So father and mother are sent to hospital again, the albumen 3+ that has urine examined is diagnosed as " nephrotic syndrome " specifically, and hospital gives him oral prednisone sheet, and urine protein is turned out cloudy after ten days, leaves hospital after 20 days.Soon, not only the state of an illness is offended again, and edema increases the weight of after taking hormone after leaving hospital, and flu is generated heat always, behind examination in hospital, show, urine protein (+++).Take Chinese medicine composition of the present invention after 20 days, the state of an illness takes a favorable turn, and it is surplus March to take Chinese medicine composition of the present invention again, and the infant mental status is good, urine protein (-), and above-mentioned symptom all disappears, stable disease, not recurrence.
6, Wang, woman, 60 years old, retired cadre.
The patient is after once " flu http://www.aliyiyao.com/topic/nkjb/hxxtjb/gm/ " before half a year, facial area and electrograph inspection occurring shows no obvious abnormalities, the bat rabat shows: both sides hydrothorax http://www.aliyiyao.com/topic/nkjb/hxxtjb/xq changes the place of examination in Urology Department, albumen (++ ++) has urine examined, albumin 13g/l, triglyceride and T-CHOL raise, give 50 milliliters of hormones, day once, play decoction being taken at a draught morning, and cooperate symptomatic treatment such as infection anticoagulant, the edema degree alleviates, but do not disappear fully, and patient's ascites is obvious.Take Chinese medicine composition of the present invention after 20 days, face and edema of pair of lower extremities disappear, and nervous sense uncomfortable in chest disappears, and it is surplus February to take Chinese medicine composition of the present invention again, and it is normal that every index is all recovered.
7, Lee, woman, 40 years old, cadre.
The patient in calendar year 2001 because upper respiratory tract infection causes morbidity, and beginning is malaise, the soreness of waist, face and edema of pair of lower extremities, edema was very serious from head to foot afterwards, also edema of eyes macular area when the most serious, urine protein (++ ++).Hospital is diagnosed as the refractory type nephrotic syndrome of healing, and is in hospital and does not feel any better half a year.The back is with the treatment of a large amount of hormones and cyclophosphamide, and albumen drops to (++), but side effect is big, after change and register the department of Chinese medicine, remove hormone while taking traditional Chinese medicine, it is many to treat half a year, albumen is (++) all the time.Take Chinese medicine composition of the present invention after 1 month, albumen begins to descend, stable disease, and take a turn for the better gradually, it is surplus April to take Chinese medicine composition of the present invention again, and thoroughly recovery from illness is resumed work, and is fine always so far.
8, Zhang, man, 24 years old, driver.
Patient 2000 is because of eyelid and facial little edema, to the chemical examination of local hospital, routine urinalysis albumen (++ ++), granular cast (++) is not felt any better behind the symptomatic treatment, for a long time and ascites is even more serious, after used a large amount of prednisones, urine routine test albumen (++ ++), granular cast (+++), after use cyclophosphamide again, still be not clearly better.Examine constantly that patient's hair almost takes off light, " moon face ", " buffalo hump " abdominal tympanites.Take Chinese medicine composition of the present invention after 1 month, edema disappears entirely, takes Chinese medicine composition of the present invention again 2 months, patient has changed a people, and symptom greatly takes a turn for the better, continuous clothes Chinese medicine composition of the present invention 6 months, every laboratory indexes all recovers normally now to marry, still in further paying a return visit.
Five, therapeutic outcome:
In the 139 routine cases of being accepted for medical treatment,, wherein cure 72 examples through treatment in 9 months, produce effects 38 examples, effective 25 examples, invalid 4 examples, total effective rate reaches 97%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment nephrotic syndrome patient.
Claims (7)
1. Chinese medicine composition for the treatment of nephrotic syndrome is characterized in that: mainly contain following bulk drugs and form:
Radix Panacis Quinquefolii 1～20 gram, the person 1～30 gram, Radix Codonopsis 1～50 gram, Radix Astragali 1～50 gram, Ganoderma 1～30 gram, Radix Angelicae Sinensis 1～50 gram, the Radix Paeoniae Alba 1～50 gram, RHIIZOMA DIOSCOREAE frOm Henan of China 1～50 gram, Carapax Trionycis 1～30 gram, Carapax et Plastrum Testudinis～30 grams, Cornu Cervi Degelatinatum 1～30 gram, Radix Rehmanniae 1～40 gram, Fructus Lycii 1～40 gram, Radix Trichosanthis 1～40 gram, Fructus Schisandrae Chinensis 1～40 gram, Semen Cuscutae 1～30 gram, Herba Cistanches 1～40 gram, Cordyceps 1～30 gram, Radix Rehmanniae Preparata 1～40 gram, Radix Polygoni Multiflori 1～40 gram, Massa Medicata Fermentata 1～50 gram, Fructus Hordei Germinatus 1～40 gram, Semen Arecae 1～40 gram, Fructus Ligustri Lucidi 1～30 gram, Pericarpium Citri Reticulatae 1～50 gram, Rhizoma Cyperi 1～40 gram, Semen Myristicae 1～30 gram, Fructus Amomi 1～30 gram, Endothelium Corneum Gigeriae Galli 1～30 gram, Semen Euryales 1～40 gram.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
Radix Panacis Quinquefolii 6 grams, the person 10 grams, Radix Codonopsis 20 grams, Radix Astragali 30 grams, Ganoderma 10 grams, Radix Angelicae Sinensis 30 grams, the Radix Paeoniae Alba 30 grams, RHIIZOMA DIOSCOREAE frOm Henan of China 30 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Cornu Cervi Degelatinatum 10 grams, Radix Rehmanniae 15 grams, Fructus Lycii 20 grams, Radix Trichosanthis 20 grams, Fructus Schisandrae Chinensis 20 grams, Semen Cuscutae 15 grams, Herba Cistanches 10 grams, Cordyceps 10 grams, Radix Rehmanniae Preparata 15 grams, Radix Polygoni Multiflori 20 grams, Massa Medicata Fermentata 30 grams, Fructus Hordei Germinatus 20 grams, Semen Arecae 15 grams, Fructus Ligustri Lucidi 15 grams, Pericarpium Citri Reticulatae 30 grams, Rhizoma Cyperi 30 grams, Semen Myristicae 20 grams, Fructus Amomi 15 grams, Endothelium Corneum Gigeriae Galli 15 grams, Semen Euryales 20 grams.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
Semen Ziziphi Spinosae 1～30 gram, Semen Raphani 1～30 gram, Fructus Crataegi 1～30 gram, Cortex Magnoliae Officinalis 1～30 gram, Fructus Chebulae's 1～30 gram, Fructus Mume 1～40 gram, Fructus Rosae Laevigatae 1～30 gram, Fructus Alpiniae Oxyphyllae 1～30 gram, Ootheca Mantidis 1～30 gram, Endoconcha Sepiae 1～30 gram, Concha Ostreae 1～30 gram, Rhizoma Drynariae 1～30 gram, Fructus Corni 1～40 gram, Cortex Lycii 1～50 gram, Cortex Phellodendri 1～40 gram, Fructus Gardeniae 1～30 gram, Radix Adenophorae (Radix Glehniae) 1～40 gram, Herba Dendrobii 1～40 gram, Rhizoma Polygonati Odorati 1～40 gram, the Rhizoma Atractylodis Macrocephalae 1～40 gram, Radix Asparagi 1～40 gram, Radix Ophiopogonis 1～40 gram, Herba Epimedii 1～30 gram, Radix Morindae Officinalis 1～30 gram, the Rhizoma Anemarrhenae 1～30 gram, Radix Puerariae 1～50 gram.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
Semen Ziziphi Spinosae 12 gram, Semen Raphani 20 grams, Fructus Crataegi 15 grams, Cortex Magnoliae Officinalis 20 grams, Fructus Chebulae's 15 grams, Fructus Mume 20 grams, Fructus Rosae Laevigatae 15 grams, Fructus Alpiniae Oxyphyllae 20 grams, Ootheca Mantidis 15 grams, Endoconcha Sepiae 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 15 grams, Fructus Corni 15 grams, Cortex Lycii 30 grams, Cortex Phellodendri 20 grams, Fructus Gardeniae 20 grams, Radix Adenophorae (Radix Glehniae) 15 grams, Herba Dendrobii 15 grams, Rhizoma Polygonati Odorati 15 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Radix Asparagi 20 grams, Radix Ophiopogonis 20 grams, Herba Epimedii 15 grams, Radix Morindae Officinalis 15 grams, the Rhizoma Anemarrhenae 15 grams, Radix Puerariae 30 gram.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment nephrotic syndrome medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910309194A CN101757540A (en) | 2009-10-31 | 2009-10-31 | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910309194A CN101757540A (en) | 2009-10-31 | 2009-10-31 | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101757540A true CN101757540A (en) | 2010-06-30 |
Family
ID=42489024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910309194A Pending CN101757540A (en) | 2009-10-31 | 2009-10-31 | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101757540A (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370760A (en) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | Compound Chinese medicinal preparation for treating nephrotic syndromeand preparation method thereof |
| CN102380055A (en) * | 2011-10-18 | 2012-03-21 | 孙克勤 | Traditional Chinese medicine composition for treating nephritic syndrome |
| CN102416094A (en) * | 2011-11-21 | 2012-04-18 | 王红 | Traditional Chinese medicine for treating chronic nephritis |
| CN102579886A (en) * | 2012-03-20 | 2012-07-18 | 王祥生 | Chinese medicine for treating nephrotic syndrome |
| CN102895522A (en) * | 2012-11-16 | 2013-01-30 | 牟炳彦 | Traditional Chinese medicine for treating pneumatosis cystoids intestinalis |
| CN102940802A (en) * | 2012-11-08 | 2013-02-27 | 刘雁 | Traditional Chinese medicine composition for treating hematuria |
| CN102988800A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Traditional Chinese medicine composition for treating hematuria and use method thereof |
| CN103127414A (en) * | 2013-03-20 | 2013-06-05 | 呼和浩特市第一医院 | Drug for treatment of chronic nephritis and early stage renal failure |
| CN103191303A (en) * | 2013-04-06 | 2013-07-10 | 隋超 | Traditional Chinese medicine for treating night sweat |
| CN104042750A (en) * | 2014-05-30 | 2014-09-17 | 闫菲菲 | Traditional Chinese medicine for treating kidney-yin deficiency |
| CN104208427A (en) * | 2014-09-16 | 2014-12-17 | 青岛华仁技术孵化器有限公司 | Pharmaceutical preparation for treating nephritic syndrome and preparation method thereof |
| CN104367916A (en) * | 2014-11-19 | 2015-02-25 | 林琳 | Traditional Chinese medicinal preparation used for treating nephrotic syndrome |
| CN104491573A (en) * | 2014-12-07 | 2015-04-08 | 范秀芳 | Pill for treating dropsical nephritis and preparation method |
| CN105660959A (en) * | 2016-04-08 | 2016-06-15 | 河南省长久健康服务中心 | Health Chinese yam breakfast tea |
| CN106215028A (en) * | 2016-04-01 | 2016-12-14 | 江鹏 | One is used for treating albuminuretic Chinese medicine preparation |
| CN106389950A (en) * | 2016-11-14 | 2017-02-15 | 王祥生 | Traditional Chinese medicine preparation for treating proteinuria of chronic nephritic syndrome |
| CN107308540A (en) * | 2017-07-04 | 2017-11-03 | 广东宜众堂生物科技有限公司 | Hyperthermia bed and its application method for treating nephrosis |
-
2009
- 2009-10-31 CN CN200910309194A patent/CN101757540A/en active Pending
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102380055A (en) * | 2011-10-18 | 2012-03-21 | 孙克勤 | Traditional Chinese medicine composition for treating nephritic syndrome |
| CN102370760A (en) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | Compound Chinese medicinal preparation for treating nephrotic syndromeand preparation method thereof |
| CN102416094B (en) * | 2011-11-21 | 2013-09-11 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating chronic nephritis |
| CN102416094A (en) * | 2011-11-21 | 2012-04-18 | 王红 | Traditional Chinese medicine for treating chronic nephritis |
| CN102579886A (en) * | 2012-03-20 | 2012-07-18 | 王祥生 | Chinese medicine for treating nephrotic syndrome |
| CN102579886B (en) * | 2012-03-20 | 2014-04-30 | 王祥生 | Chinese medicine for treating nephrotic syndrome |
| CN102988800A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Traditional Chinese medicine composition for treating hematuria and use method thereof |
| CN102940802A (en) * | 2012-11-08 | 2013-02-27 | 刘雁 | Traditional Chinese medicine composition for treating hematuria |
| CN102895522B (en) * | 2012-11-16 | 2013-10-09 | 牟炳彦 | Traditional Chinese medicine for treating pneumatosis cystoids intestinalis |
| CN102895522A (en) * | 2012-11-16 | 2013-01-30 | 牟炳彦 | Traditional Chinese medicine for treating pneumatosis cystoids intestinalis |
| CN103127414A (en) * | 2013-03-20 | 2013-06-05 | 呼和浩特市第一医院 | Drug for treatment of chronic nephritis and early stage renal failure |
| CN103191303A (en) * | 2013-04-06 | 2013-07-10 | 隋超 | Traditional Chinese medicine for treating night sweat |
| CN104042750A (en) * | 2014-05-30 | 2014-09-17 | 闫菲菲 | Traditional Chinese medicine for treating kidney-yin deficiency |
| CN104208427A (en) * | 2014-09-16 | 2014-12-17 | 青岛华仁技术孵化器有限公司 | Pharmaceutical preparation for treating nephritic syndrome and preparation method thereof |
| CN104367916B (en) * | 2014-11-19 | 2017-10-20 | 青岛市中心医院 | A kind of Chinese medicine preparation for treating nephrotic syndrome |
| CN104367916A (en) * | 2014-11-19 | 2015-02-25 | 林琳 | Traditional Chinese medicinal preparation used for treating nephrotic syndrome |
| CN104491573A (en) * | 2014-12-07 | 2015-04-08 | 范秀芳 | Pill for treating dropsical nephritis and preparation method |
| CN106215028A (en) * | 2016-04-01 | 2016-12-14 | 江鹏 | One is used for treating albuminuretic Chinese medicine preparation |
| CN105660959A (en) * | 2016-04-08 | 2016-06-15 | 河南省长久健康服务中心 | Health Chinese yam breakfast tea |
| CN106389950A (en) * | 2016-11-14 | 2017-02-15 | 王祥生 | Traditional Chinese medicine preparation for treating proteinuria of chronic nephritic syndrome |
| CN106389950B (en) * | 2016-11-14 | 2019-12-06 | 王祥生 | Traditional Chinese medicine preparation for treating chronic nephritis syndrome proteinuria |
| CN107308540A (en) * | 2017-07-04 | 2017-11-03 | 广东宜众堂生物科技有限公司 | Hyperthermia bed and its application method for treating nephrosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101757540A (en) | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof | |
| CN101816770B (en) | Traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN101757403B (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN101810833B (en) | Chinese medicinal composition for treating edema and preparation method thereof | |
| CN101816776B (en) | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof | |
| CN101711850B (en) | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method | |
| CN101757561A (en) | Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof | |
| CN101810816B (en) | Chinese medicinal composition for treating abnormal vaginal discharge and preparation method thereof | |
| CN101966313A (en) | Chinese medicinal composition for treating female infertility and preparation method thereof | |
| CN101816758B (en) | Traditional Chinese medicine composition for treating preceded menstrual cycle and preparation method thereof | |
| CN101810803A (en) | Chinese medicinal composition for treating hematuria and preparation method thereof | |
| CN101856474B (en) | Chinese medicinal composition for treating hypomenorrhea and preparation method thereof | |
| CN101810800A (en) | Chinese medicinal composition for treating skin itch and preparation method thereof | |
| CN101797352B (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101810792B (en) | Chinese medicinal composition for treating kidney failure diseases and preparation method thereof | |
| CN101972432B (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101837112B (en) | Chinese medicinal composition for curing irregular menstrual period and preparation method thereof | |
| CN101966319A (en) | Traditional Chinese medicinal composition for treating dizziness during menstruation and preparation method thereof | |
| CN101829308A (en) | Traditional Chinese medicine combination for treating amenorrhea and preparation method thereof | |
| CN101843872B (en) | Chinese medicinal composition for treating turbid urine and preparation method thereof | |
| CN101810823B (en) | Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine | |
| CN101966289A (en) | Chinese medicinal composition for treating frigidity and preparation method thereof | |
| CN101843888B (en) | Novel Chinese medicinal composition for treating menorrhagia and a preparation method thereof | |
| CN101757500A (en) | Traditional Chinese medicine composition for treating typhitis and preparation method thereof | |
| CN101780251B (en) | Chinese traditional medicine composition for eliminating blood toxicity and improving blood viscosity and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20100630 |